Effect of Vicenin-2 on ovariectomy-induced osteoporosis in rats

Biomed Pharmacother. 2020 Sep:129:110474. doi: 10.1016/j.biopha.2020.110474. Epub 2020 Jul 10.

Abstract

In worldwide, osteoporosis has become one of the severe public health distress and over 200 million people get affected by tenderness and fissure during their life period. Vicenin-2 is a naturally occurring flavonoid glycoside present in Moringa oleifera, Peperomia blanda and Ocimum sanctum Linn with numerous biological activities. The present study aims to assess the effect of Vicenin-2 on ovariectomy-induced postmenopausal osteoporosis in female rats. Surgical removal of ovaries was achieved to institute the ovariectomy animal model. The ovariectomized (OVX) animals were alienated into four groups: Control, OVX alone (model), OVX with Vicenin-2 (5 mg/kg b.w), and OVX with Vicenin-2 (10 mg/kg b.w). Also, their consistent conduct remained managed intragastrically for about 12 weeks. OVX rats treated with Vicenin-2 effectually improved body mass, uterus index, lipid profiles, inflammatory markers, bone turnover markers and amplified the presence of calcium in the OVX rat serum. Vicenin-2 was found to suppress the actions of ACP, E2, and BGP in OVX rats. Besides, Vicenin-2 showed some adverse effects over histomorphometric percentage and histological studies, in which tabular thickness and area were restored in the control and Vicenin-2 managed OVX rats. PCR results of Alp, Runx 2, Osx showed diminished expressions in OVX rats whereas treatment with Vicenin-2 displays up-regulated expression of these genes. Through our study, we established that Vicenin-2 did not wield a detrimental upshot on the skeletal organization of OVX rats. Besides, we put forward that Vicenin-2 could be an excellent candidate to treat and manage bone related disease or disorders.

Keywords: Femur; Histomorphometry; Osteoporosis; Ovariectomy; Vicenin-2; Wistar rats.

MeSH terms

  • Animals
  • Apigenin / pharmacology*
  • Biomarkers / blood
  • Bone Density / drug effects
  • Bone Density Conservation Agents / pharmacology*
  • Bone Remodeling / drug effects*
  • Bone Remodeling / genetics
  • Cytokines / blood
  • Disease Models, Animal
  • Female
  • Femur / drug effects*
  • Femur / metabolism
  • Femur / physiopathology
  • Gene Expression Regulation
  • Glucosides / pharmacology*
  • Humans
  • Inflammation Mediators / blood
  • Lipids / blood
  • Osteoporosis, Postmenopausal / genetics
  • Osteoporosis, Postmenopausal / metabolism
  • Osteoporosis, Postmenopausal / physiopathology
  • Osteoporosis, Postmenopausal / prevention & control*
  • Ovariectomy*
  • Rats, Wistar

Substances

  • Biomarkers
  • Bone Density Conservation Agents
  • Cytokines
  • Glucosides
  • Inflammation Mediators
  • Lipids
  • apigenin-6,8-di-C-glycopyranoside
  • Apigenin